資源描述：
《醫(yī)療器械行業(yè)：迎百億藍(lán)海市場(chǎng)，伴隨診斷大有可為》由會(huì)員上傳分享，免費(fèi)在線閱讀，更多相關(guān)內(nèi)容在行業(yè)資料-天天文庫(kù)。
1、目錄1、伴隨診斷市場(chǎng)繁榮.-5-1.1應(yīng)用場(chǎng)景及技術(shù)方法簡(jiǎn)述.................................................................................-5-1.2多因素推動(dòng)行業(yè)快速增長(zhǎng).................................................................................-7-2、伴隨診斷市場(chǎng)海內(nèi)外對(duì)比..........................................
2、......................................-12-2.1美國(guó)市場(chǎng)發(fā)展歷程：起步早，技術(shù)發(fā)展路徑與國(guó)內(nèi)相似............................-12-2.1.1Roche：全球體外診斷領(lǐng)域領(lǐng)導(dǎo)者...............................................................-16-2.1.2GuardantHealth：全球領(lǐng)先的綜合性液體活檢公司...................................-20-2.2日
3、本市場(chǎng)發(fā)展歷程：藥物與伴隨診斷試劑同步申請(qǐng)....................................-23-2.3中國(guó)發(fā)展歷程：小而美的企業(yè)占據(jù)細(xì)分龍頭地位........................................-25-3、伴隨診斷企業(yè)的核心競(jìng)爭(zhēng)力............................................................................-30-3.1研發(fā)能力：持續(xù)研發(fā)能力，突破儀器壁壘.......................
4、............................-30-3.2銷售能力：進(jìn)院能力及臨床認(rèn)可度...............................................................-31-3.3管理能力：把握行業(yè)方向及制定合適的戰(zhàn)略................................................-32-3.4關(guān)于行業(yè)發(fā)展的思考和探討.............................................................
5、..............-33-3.4.1藥企為何不自己做伴隨診斷？....................................................................-33-3.4.2PCR和NGS共存，哪個(gè)是發(fā)展方向？.......................................................-35-3.4.3液體活檢及聯(lián)檢化將成為趨勢(shì)...........................................................
6、.........-37-4、國(guó)內(nèi)上市公司分析............................................................................................-39-4.1艾德生物...........................................................................................................-39-4.2華大基因.......................
7、....................................................................................-40-4.3北陸藥業(yè)（世和基因、芝友醫(yī)療）...............................................................-41-4.4金域醫(yī)學(xué).......................................................................................
8、....................-41-4.5迪安診斷....................................................................................................
